• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

萘普生血浆浓度与其在实验性肝炎中的抗炎作用之间的关系。

Relationship between naproxen plasma concentration and its anti-inflammatory effect in experimental hepatitis.

作者信息

Castañeda-Hernández G, Favari L, Hoyo-Vadillo C

机构信息

Departamento de Farmcología y Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico City, Mexico.

出版信息

Arzneimittelforschung. 1995 May;45(5):585-9.

PMID:7612058
Abstract

The relationship between the plasma concentration and the anti-inflammatory effect of naproxen (CAS 22204-53-1) after oral administration of a 6 mg.kg-1 dose was studied in rats with galactosamine-induced acute hepatitis and under control conditions. In control animals naproxen peak plasma levels of 35 +/- 0.4 micrograms.ml-1 were reached in 0.5 +/- 0 h. Concentration then decayed, half-life being 5.2 +/- 0.4 h. AUC was 131 +/- 5 micrograms.h.ml-1. In intoxicated rats peak plasma levels of 29 +/- 0.3 micrograms.ml-1 were reached in 0.7 +/- 0.1 h, half-life was increased to 11.1 +/- 1.3 h, and the AUC reached 259 +/- 21 micrograms.h.ml-1. In control rats the protective effect of naproxen against carrageenan-induced inflammation increased slowly, reaching a maximum of 38% in 4 h. The protective effect against plasma concentration curve exhibited a clear counterclockwise hysteresis, probably due to a slow naproxen transport from the circulation to its site of action. In animals with hepatitis, the protective effect remained quite constant at about 40% despite variations in plasma levels, probably because the maximal effect was reached. No clear hysteresis was observed in the effect-plasma concentration curve, suggesting that naproxen arrival to its site of action was faster. Results show that the relationship between naproxen plasma concentration and its anti-inflammatory effect is complex and therefore predictions on the pharmacological response in liver damage cannot be readily made by solely considering pharmacokinetic data.

摘要

在给予6 mg.kg-1剂量萘普生(CAS 22204-53-1)口服后,研究了其血浆浓度与抗炎作用之间的关系,实验对象为半乳糖胺诱导的急性肝炎大鼠以及处于对照条件下的大鼠。在对照动物中,萘普生的血浆峰值水平在0.5±0小时达到35±0.4微克/毫升。随后浓度下降,半衰期为5.2±0.4小时。曲线下面积(AUC)为131±5微克·小时/毫升。在中毒大鼠中,血浆峰值水平在0.7±0.1小时达到29±0.3微克/毫升,半衰期增加到11.1±1.3小时,AUC达到259±21微克·小时/毫升。在对照大鼠中,萘普生对角叉菜胶诱导的炎症的保护作用缓慢增加,在4小时内达到最大值38%。保护作用与血浆浓度曲线呈现明显的逆时针滞后现象,这可能是由于萘普生从循环系统转运到其作用部位的过程缓慢。在患有肝炎的动物中,尽管血浆水平有所变化,但保护作用在约40%处保持相当稳定,可能是因为已达到最大效应。在效应-血浆浓度曲线中未观察到明显的滞后现象,这表明萘普生到达其作用部位的速度更快。结果表明,萘普生血浆浓度与其抗炎作用之间的关系较为复杂,因此不能仅通过考虑药代动力学数据就轻易预测肝损伤中的药理反应。

相似文献

1
Relationship between naproxen plasma concentration and its anti-inflammatory effect in experimental hepatitis.萘普生血浆浓度与其在实验性肝炎中的抗炎作用之间的关系。
Arzneimittelforschung. 1995 May;45(5):585-9.
2
Pharmacokinetics and pharmacodynamics of naproxen in acute experimental hepatitis.萘普生在急性实验性肝炎中的药代动力学和药效学
Arzneimittelforschung. 1993 Jun;43(6):675-9.
3
Plasma and tissue kinetics of phenylbutazone and naproxen in dogs.犬体内保泰松和萘普生的血浆及组织动力学
Arch Int Pharmacodyn Ther. 1993 Sep-Oct;325:113-28.
4
Synergistic effect of the interaction between naproxen and citral on inflammation in rats.萘普生和柠檬醛相互作用对大鼠炎症的协同效应。
Phytomedicine. 2010 Dec 15;18(1):74-9. doi: 10.1016/j.phymed.2010.05.009. Epub 2010 Jul 16.
5
Anti-inflammatory activity of polyphosphazene-based naproxen slow-release systems.聚磷腈基萘普生缓释系统的抗炎活性
J Pharm Pharmacol. 1996 May;48(5):468-73. doi: 10.1111/j.2042-7158.1996.tb05956.x.
6
[The tissue cage in dogs--a pharmacologic model for the representation of plasma and tissue kinetics].
Dtsch Tierarztl Wochenschr. 1996 May;103(5):174-7.
7
Pharmacokinetics and anti-inflammatory effect of naproxen in rats with acute and subacute spinal cord injury.萘普生在急性和亚急性脊髓损伤大鼠中的药代动力学和抗炎作用。
Naunyn Schmiedebergs Arch Pharmacol. 2020 Mar;393(3):395-404. doi: 10.1007/s00210-019-01745-9. Epub 2019 Oct 22.
8
Distinct pharmacokinetic profile and safety of a fixed-dose tablet of sumatriptan and naproxen sodium for the acute treatment of migraine.舒马曲坦与萘普生钠固定剂量片剂治疗偏头痛急性发作的药代动力学特征和安全性差异。
Headache. 2010 Mar;50(3):357-73. doi: 10.1111/j.1526-4610.2009.01606.x. Epub 2010 Feb 2.
9
[The modification of the pharmacokinetics and analgesic effect of naproxen by cimetidine, phenobarbital and thiamine diphosphate].[西咪替丁、苯巴比妥和二磷酸硫胺对萘普生药代动力学及镇痛作用的影响]
Eksp Klin Farmakol. 1996 Mar-Apr;59(2):35-7.
10
Pharmacokinetic/pharmacodynamic modeling of antipyretic and anti-inflammatory effects of naproxen in the rat.萘普生对大鼠解热和抗炎作用的药代动力学/药效学建模
J Pharmacol Exp Ther. 2001 Apr;297(1):198-205.

引用本文的文献

1
Prolonged Low-Dose Administration of FDA-Approved Drugs for Non-Cancer Conditions: A Review of Potential Targets in Cancer Cells.FDA批准的用于非癌症病症的药物的长期低剂量给药:癌细胞中潜在靶点的综述
Int J Mol Sci. 2025 Mar 18;26(6):2720. doi: 10.3390/ijms26062720.
2
Understanding the hysteresis loop conundrum in pharmacokinetic/pharmacodynamic relationships.理解药代动力学/药效动力学关系中的滞后环难题。
J Pharm Pharm Sci. 2014;17(1):34-91.
3
Pharmacokinetic-pharmacodynamic modelling of the analgesic effects of lumiracoxib, a selective inhibitor of cyclooxygenase-2, in rats.
环氧化酶-2 选择性抑制剂鲁米昔布在大鼠体内的镇痛作用的药代动力学-药效学模型研究。
Br J Pharmacol. 2010 Jan;159(1):176-87. doi: 10.1111/j.1476-5381.2009.00508.x. Epub 2009 Dec 2.
4
Clinical pharmacokinetic and pharmacodynamic profile of etoricoxib.依托考昔的临床药代动力学和药效学特征
Clin Pharmacokinet. 2008;47(11):703-20. doi: 10.2165/00003088-200847110-00002.